• Propidium Iodide: Next-Generation Approaches for Quantita...

  2025-10-01

  Explore how Propidium iodide, a premier PI fluorescent DNA stain, enables advanced, quantitative analysis of cell death pathways and genomic integrity in oncology and cell biology. This article delivers a unique focus on integrating PI with modern mechanistic assays, surpassing traditional viability and apoptosis detection.

• Annexin V as a Strategic Enabler in Translational Apoptos...

  2025-09-30

  Uncover how mechanistic insights into phosphatidylserine dynamics and early apoptosis, illuminated by Annexin V, are reshaping immune cell research and translational models of disease. This in-depth thought-leadership article examines the precision applications of Annexin V in dissecting cell death and immune imbalance, with guidance for experimental design and a forward-looking perspective on emerging frontiers.

• Annexin V: Advancing Early Apoptosis Detection in Complex...

  2025-09-29

  Explore how Annexin V, a premier phosphatidylserine binding protein, revolutionizes apoptosis detection in intricate immune microenvironments. This article uncovers unique applications in immune tolerance modeling and integrates new insights from placental immunology and disease research.

• Bortezomib (PS-341): Advanced Proteasome Inhibition in Mi...

  2025-09-28

  Explore how Bortezomib (PS-341), a pioneering reversible proteasome inhibitor, reveals novel links between 20S proteasome inhibition, mitochondrial proteostasis, and apoptosis in cancer therapy. This in-depth analysis uniquely integrates emerging mitochondrial regulation mechanisms with advanced research applications.

• Bortezomib (PS-341): Advancing Proteasome Inhibitor Resea...

  2025-09-27

  Explore how Bortezomib (PS-341), a potent reversible proteasome inhibitor, is revolutionizing cancer therapy and mitochondrial proteostasis research. This article provides an advanced, integrative analysis of Bortezomib’s mechanistic role in apoptosis, metabolic regulation, and its unique potential revealed by emerging mitochondrial studies.

• Bortezomib (PS-341): Decoding Proteasome Inhibition and P...

  2025-09-26

  Discover how Bortezomib (PS-341), a reversible proteasome inhibitor, uniquely illuminates the interplay between proteasome signaling and pyrimidine salvage pathways in cancer. This in-depth article explores advanced applications, mechanistic insights, and future directions for multiple myeloma and mantle cell lymphoma research.

• Y-27632 Dihydrochloride: Advanced ROCK Inhibition in Huma...

  2025-09-25

  Explore how Y-27632 dihydrochloride, a potent and selective ROCK inhibitor, unlocks new frontiers in human intestinal stem cell aging, regeneration, and cancer research. This in-depth article uniquely integrates molecular mechanisms, translational opportunities, and practical guidance for cytoskeletal and stem cell studies.

• Cy5-UTP: Illuminating Phase Separation in RNA-Protein Int...

  2025-09-24

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) empowers the study of RNA-protein phase separation and virus-host interactions through advanced fluorescent RNA labeling. Discover technical insights and new applications in molecular biology that extend beyond traditional labeling strategies.

• DMH1 as a Selective BMP Type I Receptor Inhibitor in Orga...

  2025-09-23

  Explore the role of DMH1, a selective BMP type I receptor inhibitor, in modulating BMP signaling for advanced organoid systems and non-small cell lung cancer research. This article reviews current findings, practical deployment, and emerging strategies for leveraging DMH1 in high-fidelity cellular models.

• 2-Pyridylethylamine dihydrochloride reagent br Materials and

  2025-03-03

  

  Materials and Methods Results In the Base Analysis (53% of patients having access to the ALK test in both Current and Alternative Scenarios), a total of 16,583 patients were tested of whom 1,252 were assumed to be ALK-positive. A more extensive use of Ventana in the Alternative Scenario determ

• Glycerol dehydratase GDHt EC is a key enzyme for the

  2025-03-03

  

  Glycerol dehydratase (GDHt, EC 4.2.1.30) is a key enzyme for the bioconversion of glycerol into the value-added chemicals and thereby has recently attracted a great deal of attention as an essential component for metabolic engineering . GDHt carries out a radical-mediated turnover of glycerol into 3

• A rate limiting step in the generation of kynurenine

  2025-03-03

  

  A rate-limiting step in the generation of kynurenine and xanthurenic oxidative phosphorylation is the oxidation of N-formyl-kynurenine to l-kynurenine via indolamine 2,3-dioxygenase (IDO) or tryptophan dioxygenase (TDO). IDO and/or TDO knockdown decreases and ectopic over-expression increases produc

• sVRPs were more sensitive to ABT than MSRs

  2025-03-03

  

  sVRPs were more sensitive to ABT-702 than MSRs. This result agrees with previous reports that the activation of A1 receptors more potently inhibits sVRPs than MSRs (Nakamura et al., 1997, Otsuguro et al., 2009). Importantly, sVRPs are thought to reflex C-fiber-evoked nociceptive transmission. Nocice

• Our studies also reveal the normal functional roles of the

  2025-03-03

  

  Our studies also reveal the normal functional roles of the MIR. Interaction between the MIR loop and the N-terminal α helix nucleates conformational maturation of AChR subunits, thereby promoting assembly of mature AChRs [52], [55]. This interaction in homologous parts of all AChR subunits appears t

• With the treatment options available today

  2025-03-03

  

  With the treatment options available today including a combination of symptomatic treatments and general immunosuppression, many MG patients can lead productive lives [1], [4], [20]. The frequency of death has decreased due to improved management and detection of milder cases. At present, the overal

16399 records 5/1094 page Previous Next 12345 下5页 Last page